Scholarlink

Background <p>This study aimed to investigate the measurement properties of the Hospital Anxiety and Depression Scale (HADS) for patients with breast hypertrophy undergoing breast reduction in the public health care system. Depression and anxiety are two symptoms that can be taken into consideration when patients are evaluated for breast reduction and are part of the patient-reported outcomes (PROMs) used to measure the effect of an operation.</p> Methods <p>The HADS was administered to women both pre- and postoperatively. Confirmatory Factor Analysis, internal consistency, test–retest reliability, construct validity, and responsiveness were analysed.</p> Results <p>The study included 276 patients who completed pre-operative HADS assessments, with 52 undergoing test–retest analysis and 52 completing post-operative assessments. Internal consistency was acceptable (Cronbach’s α: HADS-A = 0.85, HADS-D = 0.87), and construct validity showed strong correlations with BDI and BAI and moderate negative correlation with BREAST-Q. Confirmatory factor analysis supported both two- and three-factor models, though the two-factor model was preferred. Test–retest reliability (ICC: HADS-A = 0.81, HADS-D = 0.75) and responsiveness were satisfactory. No floor or ceiling effects were observed.</p> Conclusions <p>HADS is a valid tool, with sound psychometric properties, for assessing depression and anxiety in women undergoing breast reduction.</p> Trial registration <p>ClinicalTrials.Gov Identifier NCT05233891.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Creating a standard for evaluation of symptoms of depression and anxiety in women undergoing reduction mammaplasty: validation and reliability of HADS

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年9月22日

查看全文
  • Emma Hansson,
  • Catrin Wessman,
  • Anna Paganini

摘要

Background

This study aimed to investigate the measurement properties of the Hospital Anxiety and Depression Scale (HADS) for patients with breast hypertrophy undergoing breast reduction in the public health care system. Depression and anxiety are two symptoms that can be taken into consideration when patients are evaluated for breast reduction and are part of the patient-reported outcomes (PROMs) used to measure the effect of an operation.

Methods

The HADS was administered to women both pre- and postoperatively. Confirmatory Factor Analysis, internal consistency, test–retest reliability, construct validity, and responsiveness were analysed.

Results

The study included 276 patients who completed pre-operative HADS assessments, with 52 undergoing test–retest analysis and 52 completing post-operative assessments. Internal consistency was acceptable (Cronbach’s α: HADS-A = 0.85, HADS-D = 0.87), and construct validity showed strong correlations with BDI and BAI and moderate negative correlation with BREAST-Q. Confirmatory factor analysis supported both two- and three-factor models, though the two-factor model was preferred. Test–retest reliability (ICC: HADS-A = 0.81, HADS-D = 0.75) and responsiveness were satisfactory. No floor or ceiling effects were observed.

Conclusions

HADS is a valid tool, with sound psychometric properties, for assessing depression and anxiety in women undergoing breast reduction.

Trial registration

ClinicalTrials.Gov Identifier NCT05233891.